3-phenoxybenzoic acid has been researched along with Parkinson Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, X; Hu, J; Kou, L; Li, Y; Sun, Y; Wan, F; Wang, T; Wu, J; Yin, S; Yu, T; Zhang, Z; Zhou, Q; Zou, W | 1 |
1 other study(ies) available for 3-phenoxybenzoic acid and Parkinson Disease
| Article | Year |
|---|---|
The pyrethroids metabolite 3-phenoxybenzoic acid induces dopaminergic degeneration.
Topics: Animals; Benzoates; Dopamine; Dopaminergic Neurons; Mammals; Mice; Parkinson Disease; Pyrethrins | 2022 |